Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.
Journal: Radiology
Published: March 31, 2026
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 08, 2026
Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 30, 2025
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate.
Journal: Clinical genitourinary cancer
Published: June 14, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancer.
Journal: Cancer
Published: April 25, 2024
Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
Journal: JCO precision oncology
Published: September 14, 2022
Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.
Journal: The Annals of thoracic surgery
Published: June 06, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026